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Adolescence is a critical period in CF patients on many points. However, there
are only few studies on this problem. Most of them refer to quality of life
but not psychological or psychopathological aspects. Therefore we undertook an
observational study on the patients above 13 years in our CF Center. The aim was
to study psychological functioning and to list psychopathological dysfunctions.
Patients completed the Cystic Fibrosis Questionnaire for the adolescent. We added
to this self-questionnaire a semi-directive interview scale that we built. This scale
includes medical, social, psychological and psychopathological ﬁelds. We used the
ICD-10 to classify the psychopathological categories.
55 patients were included: mean age 15 years. We noticed that 50% of them present
a psychopathology. 30% with a real psychological trouble such as mild, moderate or
severe depression, global anxiety; and 20% with adjustment disorders. There was an
increased prevalence of family dysfunction (51%) such as problems in relationship,
or parental overprotection.
51% had a bad or moderate compliance. 50% of our patients complained about dor-
sal or abdominal pain. We realized that this dimension was primary underestimated
in our interview.
This study demonstrates that CF adolescents have a speciﬁc psychopathological
symptomatology that may interfere with the course of their disease. Careful
psychological support should be reinforced during this period for the adolescent
and his family.
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In line with the developments in medicine, the survival of cystic ﬁbrosis patients
has increased progressively and been extended beyond childhood. However, still
being a life-threatening illness, cystic ﬁbrosis has many consequences in terms
of the psychosocial well-being. Family Systems Perspective, brought about the
realization that a chronic illness does not only impact the individual child, but
also transmit its effects to the entire family system. Living with a chronic illness,
is an ongoing trauma especially for the parents as the primary caregivers. The
present study aims to investigate the emergence of posttraumatic stress symptoms
in the families of children with cystic ﬁbrosis, by utilizing a conceptual model.
Assuming that the factors inﬂuencing parents’ responses to illness-related trauma
are multiple, the model incorporates demographics, illness characteristics (both
objective and appraised) and social-ecological variables as primary predictors. The
sample of this ongoing research consists of parents of children with cystic ﬁbrosis.
The anticipated number of participants is 50 mothers and 50 fathers. The data has
been gathered through the use of self-report questionnaires. Hierarchical Regression
Technique will be used to analyze the data. The results are believed to provide
a useful framework to organize researchers’ and clinicians’ thinking about the
psychological responses of the families living with cystic ﬁbrosis and the factors
that inﬂuence them. An improved understanding of the role of different predictive
variables, functioning either as risk or protective factors, is expected to be helpful
in designing psychosocial interventions for the families.
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Background: Having a chronic illness such as CF is a risk factor for the devel-
opment of internalizing psychopathology, which in turn might affect psychosocial
functioning and quality of life. As it has often been reported that quality of life
is only modestly associated with disease severity, we expected life satisfaction to
have a stronger association with mental health parameters, compared to parameters
of physical health.
Method: During a routine clinic visit 348 German CF patients (12−64 yrs, M= 23.2,
SD= 9.1) ﬁlled in the Hospital Anxiety and Depression Scale (HADS), screening
for symptoms of anxiety and depression, and the Questions on Life Satisfaction
(FLZ), measuring general, health-related and CF-speciﬁc life satisfaction. These
were correlated with health parameters (BMI, FEV1%).
Results: 8.6% of patients had elevated depression scores, whereas 19.3% reported
high levels of anxiety. Signiﬁcant negative correlations (r = −0.3 to −0.6) were
observed between the HADS scores and general, health-related and CF-speciﬁc
life satisfaction. The correlations were highest for depression and life satisfaction
(r = −0.56 to −0.61). Only slight negative correlations were found between symptoms
of depression and anxiety and lung function (r = −0.2). BMI showed no signiﬁcant
association with the HADS scores. All correlations were maintained when the
sample was analysed stratiﬁed by pulmonary function.
Discussion: As expected, life satisfaction was associated with the level of anxiety
and depression reported. Addressing patients’ psychopathology might help to
improve patients life satisfaction, positively inﬂuencing therapy adherence and
disease management.
Supported by: German CF Foundation.
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Background: Chronic conditions such as cystic ﬁbrosis (CF) and mental health of
patients and their caregivers are closely associated. Co-morbid psychopathology is
a relevant factor in treatment of CF. In this exploratory cross-sectional study we
looked at the correlation of anxiety/depression in adolescents with CF and their
caregivers.
Method: 85 German CF patients (12−17 years, M= 14.2, SD= 1.6; 62% male) and
their accompanying caregivers (88% mothers) independently ﬁlled in the Hospital
Anxiety and Depression Scale (HADS), screening for symptoms of anxiety and
depression. Separate ranking lists of the most prevalent symptoms were determined.
Concordance rates of parents’ and patients’ screening results and correlations of
symptom scores were calculated.
Results: Feeling tense, restless, or fearful were the most prevalent symptoms
reported by parents and adolescents. 30.6% of the parents and 10.6% of patients had
at least mildly elevated anxiety scores, whereas 18.8% of caregivers and none of
the patients reported elevated levels of depression. The concordance rate for anxiety
was 67% (6 of 9 nine dyads). Caregiver-patient anxiety scores were signiﬁcantly
correlated (r = 0.36, p< 0.01).
Discussion: Symptoms of anxiety are common in CF families, probably reﬂecting
the life threatening character of the disease. Adolescent patients report to be free
from depression, however every ﬁfths caregiver is at least mildly depressed. High
concordance rate of anxiety may be due to parental modelling and genetic factors.
Further studies should investigate the impact of co-morbid psychopathology on the
course of CF, especially with regard to interaction effects between adolescents and
their caregivers.
Supported by: German CF Foundation.
